Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3285634rdf:typepubmed:Citationlld:pubmed
pubmed-article:3285634lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:3285634lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3285634lifeskim:mentionsumls-concept:C0020445lld:lifeskim
pubmed-article:3285634lifeskim:mentionsumls-concept:C0033215lld:lifeskim
pubmed-article:3285634pubmed:issue1lld:pubmed
pubmed-article:3285634pubmed:dateCreated1988-6-20lld:pubmed
pubmed-article:3285634pubmed:abstractTextNine children with familial hypercholesterolaemia, age range 2 to 12 years, were treated with a low cholesterol diet and probucol (10 mg/kg/day). The year before, the children received, as only treatment, a low fat-cholesterol diet. During this period their mean plasma total cholesterol level fell from 8.2 +/- 1.45 mmol/l to 7.17 +/- 0.84 mmol/l (12.6%). This level was further reduced to 5.92 +/- 0.63 mmol/l (17.1%) after the addition of probucol. Plasma high density lipoprotein cholesterol levels were lowered in absolute terms but not in relation to total cholesterol. No apparent side effects were observed. However, the use of probucol should be restricted for the moment to severe cases of hypercholesterolaemia as the long-term excretion of the drug in children is not yet known.lld:pubmed
pubmed-article:3285634pubmed:languageenglld:pubmed
pubmed-article:3285634pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3285634pubmed:citationSubsetIMlld:pubmed
pubmed-article:3285634pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3285634pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3285634pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3285634pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3285634pubmed:statusMEDLINElld:pubmed
pubmed-article:3285634pubmed:monthJanlld:pubmed
pubmed-article:3285634pubmed:issn0001-656Xlld:pubmed
pubmed-article:3285634pubmed:authorpubmed-author:SanjurjoPPlld:pubmed
pubmed-article:3285634pubmed:authorpubmed-author:MartulPPlld:pubmed
pubmed-article:3285634pubmed:authorpubmed-author:SasietaMMlld:pubmed
pubmed-article:3285634pubmed:authorpubmed-author:LafuentePPlld:pubmed
pubmed-article:3285634pubmed:authorpubmed-author:ArizaFFlld:pubmed
pubmed-article:3285634pubmed:authorpubmed-author:CabezaIIlld:pubmed
pubmed-article:3285634pubmed:issnTypePrintlld:pubmed
pubmed-article:3285634pubmed:volume77lld:pubmed
pubmed-article:3285634pubmed:ownerNLMlld:pubmed
pubmed-article:3285634pubmed:authorsCompleteYlld:pubmed
pubmed-article:3285634pubmed:pagination132-5lld:pubmed
pubmed-article:3285634pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:meshHeadingpubmed-meshheading:3285634-...lld:pubmed
pubmed-article:3285634pubmed:year1988lld:pubmed
pubmed-article:3285634pubmed:articleTitleTreatment with probucol of children with familial hypercholesterolaemia.lld:pubmed
pubmed-article:3285634pubmed:affiliationDepartment of Paediatrics, Cruces Children's Hospital, Bilbao, Spain.lld:pubmed
pubmed-article:3285634pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3285634pubmed:publicationTypeClinical Triallld:pubmed